Published in BMJ on July 03, 2004
Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies. CMAJ (2006) 2.40
Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview. PLoS Med (2011) 2.06
Assessing the benefit-harm balance at the bedside. BMJ (2004) 1.77
Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovascular events. Br J Clin Pharmacol (2008) 1.39
The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses. Arthritis Res Ther (2011) 1.04
When are observational studies as credible as randomised trials? Lancet (2004) 6.19
Assessing the quality of research. BMJ (2004) 3.90
Choosing the best research design for each question. BMJ (1998) 3.03
The discovery of drug-induced illness. N Engl J Med (1977) 2.29
Reporting of adverse drug reactions in randomised controlled trials - a systematic survey. BMC Clin Pharmacol (2001) 2.25
The case for recording events in clinical trials. Br Med J (1977) 2.23
Balancing benefits and harms in health care. BMJ (2003) 2.01
Synthesising licensing data to assess drug safety. BMJ (2004) 1.48
A comparison of three different sources of data in assessing the frequencies of adverse reactions to amiodarone. Br J Clin Pharmacol (2004) 1.45
Observational research and evidence-based medicine: What should we teach young physicians? J Clin Epidemiol (1998) 1.38
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet (2007) 20.57
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ (2007) 14.52
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol (2008) 14.36
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med (2007) 8.77
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med (2007) 8.46
Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum (2004) 7.79
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ (2007) 5.38
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology (2007) 5.12
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev Med (2007) 4.29
Assessing the quality of research. BMJ (2004) 3.90
Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA (2005) 3.04
When one depends on the other: reporting of interaction in case-control and cohort studies. Epidemiology (2009) 2.54
A regression model with unexplained residuals was preferred in the analysis of the fetal origins of adult diseases hypothesis. J Clin Epidemiol (2005) 2.39
Heredity versus environment in tuberculosis in twins: the 1950s United Kingdom Prophit Survey Simonds and Comstock revisited. Am J Respir Crit Care Med (2007) 2.30
Commentary: A structural approach to Berkson's fallacy and a guide to a history of opinions about it. Int J Epidemiol (2014) 2.23
Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs. Pharmacoepidemiol Drug Saf (2013) 2.01
Case-control and two-gate designs in diagnostic accuracy studies. Clin Chem (2005) 1.98
An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source? Clin Infect Dis (2007) 1.94
Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis. Arthritis Rheum (2004) 1.94
Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern Med (2013) 1.91
[The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies]. Gac Sanit (2008) 1.87
Overestimation of risk ratios by odds ratios in trials and cohort studies: alternatives to logistic regression. CMAJ (2011) 1.70
What do case-control studies estimate? Survey of methods and assumptions in published case-control research. Am J Epidemiol (2008) 1.67
Efficacy of experimental treatments compared with standard treatments in non-inferiority trials: a meta-analysis of randomized controlled trials. Int J Epidemiol (2010) 1.60
Should preregistration of epidemiologic study protocols become compulsory? Reflections and a counterproposal. Epidemiology (2012) 1.47
Distinguishing case series from cohort studies. Ann Intern Med (2012) 1.42
A test-negative design with additional population controls can be used to rapidly study causes of the SARS-CoV-2 epidemic. Epidemiology (2020) 1.40
[The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies]. Rev Esp Salud Publica (2008) 1.35
Multisystem morbidity and mortality in Cushing's syndrome: a cohort study. J Clin Endocrinol Metab (2013) 1.32
Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion (2007) 1.29
Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol (2007) 1.18
Case reports of suspected adverse drug reactions: case reports were dismissed too quickly. BMJ (2006) 1.17
Endogenous subclinical thyroid disorders, physical and cognitive function, depression, and mortality in older individuals. Eur J Endocrinol (2011) 1.13
Quantification of bias in direct effects estimates due to different types of measurement error in the mediator. Epidemiology (2012) 1.11
Why do the results of randomised and observational studies differ? BMJ (2011) 1.04
Relationship between venous and arterial thrombosis: a review of the literature from a causal perspective. Semin Thromb Hemost (2011) 1.00
A mapping between interactions and interference: implications for vaccine trials. Epidemiology (2012) 0.97
Was the LIFE trial independent? Lancet (2002) 0.96
In an observational study elderly patients had an increased risk of falling due to home hazards. J Clin Epidemiol (2005) 0.94
Cognitive development of singletons born after intracytoplasmic sperm injection compared with in vitro fertilization and natural conception. Fertil Steril (2007) 0.94
Health risks encountered by Dutch medical students during an elective in the tropics and the quality and comprehensiveness of pre-and post-travel care. BMC Med Educ (2010) 0.94
Incidence of recombinant erythropoietin (EPO) hyporesponse, EPO-associated antibodies, and pure red cell aplasia in dialysis patients. Kidney Int (2005) 0.92
Serum troponin T concentration as a predictor of mortality in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis (2006) 0.92
Prophylactic corticosteroids for cardiopulmonary bypass in adults. Cochrane Database Syst Rev (2011) 0.92
BMI and mortality among adults with incident type 2 diabetes. N Engl J Med (2014) 0.90
Reporting of noninferiority trials was incomplete in trial registries. J Clin Epidemiol (2011) 0.87
Survival of patients with epilepsy: an estimate of the mortality risk. Epilepsia (2002) 0.87
Bortezomib in multiple myeloma. N Engl J Med (2005) 0.86
Trends in total cholesterol screening and in prescribing lipid-lowering drugs in general practice in the period 1994-2003. BMC Fam Pract (2008) 0.85
Opportunities for enhancing the FDA guidance on pharmacovigilance. JAMA (2008) 0.84
ACE I/D polymorphism is associated with mortality in a cohort study of patients starting with dialysis. Kidney Int (2005) 0.84
Matched follow-up study of 5-8 year old ICSI-singletons: comparison of their neuromotor development to IVF and naturally conceived singletons. Hum Reprod (2007) 0.83
Reporting instrumental variable analyses. Epidemiology (2013) 0.83
Registering observational research: second thoughts. Lancet (2010) 0.83
Dutch perinatal mortality. Study did a good job. BMJ (2010) 0.83
Female donors and transfusion-related acute lung injury: A case-referent study from the International TRALI Unisex Research Group. Transfusion (2010) 0.82
Thrombophilias and gynaecology. Best Pract Res Clin Obstet Gynaecol (2003) 0.82
Sick leave as a predictor of job loss in patients with chronic arthritis. Int Arch Occup Environ Health (2006) 0.82
Preemptive versus Non-preemptive simultaneous pancreas-kidney transplantation: a single-center, long-term, follow-up study. Transplantation (2006) 0.82
Continuing controversies over "risks and rates"--more than a century after William Farr's "On prognosis". Soz Praventivmed (2003) 0.81
A solution to the problem of studying blood donor-related risk factors when patients have received multiple transfusions. Transfusion (2010) 0.81
One-time general consent for research on biological samples: opt out system for patients is optimal and endorsed in many countries. BMJ (2006) 0.81
Perinatal outcome, health, growth, and medical care utilization of 5- to 8-year-old intracytoplasmic sperm injection singletons. Fertil Steril (2008) 0.80
Associations between vitamin D receptor genotypes and mortality in a cohort of older Dutch individuals. Eur J Endocrinol (2010) 0.80
A meta-analysis of surgical treatment for vestibular schwannoma: is hospital volume related to preservation of facial function? Otol Neurotol (2009) 0.80
A possible overestimation of the effect of aspirin. Arch Intern Med (2007) 0.79
Determinants of methicillin-resistant Staphylococcus aureus carriage in nursing homes. Age Ageing (2007) 0.79
Commentary: strengthening the reporting of observational epidemiology the STROBE statement. Int J Epidemiol (2007) 0.78
Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients. J Natl Cancer Inst (2015) 0.78
Physician's preference-based instrumental variable analysis: is it valid and useful in a moderate-sized study? Epidemiology (2014) 0.78
Factor V Leiden and venous thromboembolism. Ann Intern Med (2004) 0.78
Overweight, obesity, and mortality. N Engl J Med (2006) 0.77
Travel and venous thrombosis: an exercise in thinking about bias. Ann Intern Med (2009) 0.75
Oral contraceptives and the risk of myocardial infarction. N Engl J Med (2002) 0.75
Do editors live up to the Sept 10, 2001, expectations? Lancet (2002) 0.75
Re: "quality of reporting of observational longitudinal research". Am J Epidemiol (2005) 0.75
What conclusions should be drawn between critical care physician management and patient mortality in the intensive care unit? Ann Intern Med (2008) 0.75
More on the LIFE study. Lancet (2003) 0.75
RE: Drug risk assessment and data reuse. Pharmacoepidemiol Drug Saf (2014) 0.75
Analytic approaches to observational studies with treatment selection bias. JAMA (2007) 0.75
Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst (2003) 0.75
Resistance after selective decontamination. Lancet Infect Dis (2012) 0.75
Trends in citations to books on epidemiological and statistical methods in the biomedical literature. PLoS One (2013) 0.75
Balancing benefits and harms in health care: observational data on harm should complement systematic reviews of benefit. BMJ (2003) 0.75
Population screening for single genes that codetermine common diseases in adulthood had limited effects. J Clin Epidemiol (2006) 0.75
Exposure Opportunity: The Advantages of Including Men in Analyses of Female-Related Risk Factors. Am J Epidemiol (2017) 0.75
[Causality: risk factors and interventions]. Ned Tijdschr Geneeskd (2013) 0.75
[Case-control study: the importance of selecting the right controls]. Ned Tijdschr Geneeskd (2013) 0.75
Myocardial infarction occurs with a similar 24 h pattern in the 4G/5G versions of plasminogen activator inhibitor-1. Chronobiol Int (2009) 0.75